TY - JOUR
T1 - Chromogranin positive cells in colorectal carcinoma and transitional mucosa
AU - Mori, M.
AU - Mimori, K.
AU - Kamakura, T.
AU - Adachi, Y.
AU - Ikeda, Y.
AU - Sugimachi, K.
PY - 1995
Y1 - 1995
N2 - Aims-Immunostaining of chromogranin identifies gastrointestinal mucosal endocrine cells. The detailed distribution and significance of chromogranin positive cells in colorectal carcinomas and in transitional mucosa remain unclear. The aim of this study was to clarify these aspects. Methods-The distribution of chromogranin positive cells was studied by immunohistochemical methods in normal epithelium remote from carcinoma, in transitional mucosa, and in carcinomas of the colorectum. In selected cases northern or western blot analyses were performed. Results-Chromogranin positive cells were seen in the lower third of the normal crypts and less frequently in transitional mucosa. Thirty five per cent (n=38) of colorectal carcinomas showed immunohistochemically positive carcinoma cells in the tumour tissue. Northern and western blot analyses showed similar results. There was no difference in clinicopathological factors, including prognosis, between chromogranin positive cases of colorectal carcinoma (n = 38) and chromogranin negative cases (n = 70). Conclusions-Neuroendocrine cell differentiation is controlled in transitional mucosa and the presence of chromogranin positive cells in carcinoma tissue does not influence the patient's prognosis.
AB - Aims-Immunostaining of chromogranin identifies gastrointestinal mucosal endocrine cells. The detailed distribution and significance of chromogranin positive cells in colorectal carcinomas and in transitional mucosa remain unclear. The aim of this study was to clarify these aspects. Methods-The distribution of chromogranin positive cells was studied by immunohistochemical methods in normal epithelium remote from carcinoma, in transitional mucosa, and in carcinomas of the colorectum. In selected cases northern or western blot analyses were performed. Results-Chromogranin positive cells were seen in the lower third of the normal crypts and less frequently in transitional mucosa. Thirty five per cent (n=38) of colorectal carcinomas showed immunohistochemically positive carcinoma cells in the tumour tissue. Northern and western blot analyses showed similar results. There was no difference in clinicopathological factors, including prognosis, between chromogranin positive cases of colorectal carcinoma (n = 38) and chromogranin negative cases (n = 70). Conclusions-Neuroendocrine cell differentiation is controlled in transitional mucosa and the presence of chromogranin positive cells in carcinoma tissue does not influence the patient's prognosis.
UR - http://www.scopus.com/inward/record.url?scp=0029091223&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029091223&partnerID=8YFLogxK
U2 - 10.1136/jcp.48.8.754
DO - 10.1136/jcp.48.8.754
M3 - Article
C2 - 7560204
AN - SCOPUS:0029091223
SN - 0021-9746
VL - 48
SP - 754
EP - 758
JO - Journal of Clinical Pathology
JF - Journal of Clinical Pathology
IS - 8
ER -